Relation between serum vitamin B₁₂ level and duration of treatment with carbamazepine in epilepsy patients

Abstract

Vitamin B₁₂ levels in the serum of 58 epileptic patients receiving only carbamazepine for at least 6 months were measured. Same number of epilepsy patients with no history of taking antiepileptic medicine were taken as control. The mean level of vitamin B₁₂ in carbamazepine-treated epileptic patients was 265.5 pg/mL whereas it was 478.3 pg/mL in control. Increased duration of treatment of carbamazepine in epilepsy caused significantly decreased level of serum vitamin B₁₂ (Pearson correlation coefficient, r = -0.9, p<0.0001). In conclusion, serum vitamin B₁₂ level significantly decreased in relation to duration of carbamazepine treatment in epileptic patients.